
    
      The objectives of the proposed research are to 1) evaluate the effect of co-occurring AnxD on
      the severity of biological stress-mood system dysregulations in AUD inpatients at
      pre-treatment, 2) evaluate the effect of co-occurring AnxD on the persistence of stress-mood
      system dysregulations in AUD inpatients in the months following treatment, 3) evaluate the
      effects of treatment on biological stress-mood system re-regulation among AUD patients with
      co-occurring AnxD, and 4) evaluate the effect of re-regulation change in biological
      stress-mood system function on AUD clinical outcomes.
    
  